The Healthcare sector has traditionally been well represented in the convertible bond universe, usually ranking only behind Technology in size. Healthcare companies opt to issue convertible bonds for varying reasons, including balance sheet considerations, acquisitions, debt refinancing, or share repurchases. Biotechnology & specialty pharma companies, in particular, have historically utilized the convertible bond asset class considerably to finance their growth objectives.
How Investing in Uncorrelated Strategies Can Hurt Portfolio Performance
SSI highlights the importance of considering correlation alongside other key variables, such as expected returns,